Your provider in Nocatee or Ponte Vedra can tailor a plan that fits your energy levels and lifestyle
GLP-1s do come with some risks, and can be expensive, subject to shortages, or not covered by insurance, so its wise to make an informed decision about whether theyre the right choice before starting them
Clinical Oversight: Ensuring safe prescribing and preventing misuse will require robust monitoring systems
Sources: 1 Medication Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss FDA 2 GLP-1 agonists: Diabetes drugs and weight loss Mayo Clinic 3 GLP-1 Drugs Comparison GoodRx FDA Drug Release Info: Adlyxin: FDA approves Adlyxin to treat type 2 diabetes | FDA Byetta: Drug Approval Package: Byetta (Exenatide) NDA #021773 (fda.gov) Mounjaro: FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes | FDA Ozempic: FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 FDA Rybelsus: FDA approves first oral GLP-1 treatment for type 2 diabetes FDA Saxenda: FDA approves weight management drug for patients aged 12 and older | FDA Trulicity: FDA Drug Approval Package Victoza: FDA Drug Apprival Package Wegovy: FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
Kraus MB, Dodd SE, Sharpe EE
Conclusion In conclusion, GLP-1 represents a significant advancement in weight management
